proTect – New concepts for in vitro evaluation of the biocompatibility of materials and medical products

This page contains automated translations.

Project duration: 1 October 2016 to 30 September 2021

Increasingly complex materials and medical products are being used in medicine that have an effect on the organism by negatively interfering with the metabolism of cells and can thus cause inflammatory reactions or allergies that lead to material intolerance. To prevent this, it is important to test these materials and medical products for their biocompatibility. The project goal is to combine the expertise of the Immunology, Signalling Pathways and Bioinformatics working groups at the Department of Applied Life Sciences and the Austrian Research Institute for Chemistry and Engineering (OFI) in a collaborative project. The aim is to develop an in vitro test system to assess the biocompatibility of test substances that come into direct contact with human tissue. These include invasive medical devices, biosensors and catheters.

The project is divided into three parts: in the first part, established human cell cultures (e.g. epithelial cells, immune cells) are treated in vitro with materials and medical products. The influence of the materials on the cells is determined by analysing the protein expression profiles of the treated cells using high-resolution mass spectrometry. In a second part, established immunological methods are used to analyse whether the materials activate the innate or adaptive immune system and can trigger inflammatory reactions or allergies. A third part concentrates on classical toxicological parameters, which are evaluated with the aid of microscopic high content screening. Results from the three sub-projects will allow a comprehensive assessment of the biocompatibility of the materials. This development will make it possible to replace animal experiments with reliable in vitro test systems.

Research objectives

  • Production of extracts from various invasive medical devices
  • Development of a proteomics-based test system to evaluate the biocompatibility of medical devices
  • Analysing the allergic potential (type I and type IV allergy) of the medical devices
  • Toxicological analysis of medical devices using established tests and microscopic high content screening
  • New development of cell-based tests to detect inflammation-promoting components of the medical devices
  • Dissemination of the results

Research Field (until 31 July 2020)

Research field Allergy Research

Cell Based Test Systems research field

Since 1 August 2020, five interdisciplinary research areas have replaced existing research fields.

Contact us

Project Lead

Project Team


Study Programs Involved

Master

Molecular Biotechnology

full-time

Bachelor

Molecular Biotechnology

full-time